Stacy Markel - Feb 28, 2023 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief People Officer
Signature
Stacy Markel, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 05:02 PM
Previous filing
Aug 31, 2022
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NUVB Class A Common Stock 4.59K Feb 28, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +500K $0.00 500K Feb 28, 2023 Class A Common Stock 500K $1.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,000 shares acquired on May 19, 2022 and 70 shares acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date